Table 4.
Administration | Agent | Dosage (ng/kg) | Diameter of remnant ulcer (μm) | Thickness of granulation tissue (μm) |
im | Saline control | 3 928 ± 636 | 718 ± 165 | |
Excipient control | 3 981 ± 594 | 652 ± 169 | ||
Famotidine | 40 000 | 3 175 ± 577b | 768 ± 268 | |
BPC 157 | 200 | 3 266 ± 671a | 992 ± 295b | |
BPC 157 | 400 | 2 658 ± 744b | 1 018 ± 202b | |
BPC 157 | 800 | 2 426 ± 511b | 1 012 ± 306b | |
ig | Saline control | 4 098 ± 795 | 673 ± 112 | |
Famotidine | 40 000 | 1 772 ± 458b | 805 ± 100a | |
BPC 157 | 200 | 3 260 ± 728a | 797 ± 110a | |
BPC 157 | 400 | 2 972 ± 564b | 837 ± 114b | |
BPC 157 | 800 | 2 904 ± 577b | 862 ± 171b |
P < 0.05,
P < 0.01 vs excipient control (im) or saline control (ig).